【4563】アンジェス MG : AnGes Group Receives FDA Approval of a Revised SPA for Phase III Clinical Trial for Collategene, a Drug for Ischemic Disease Treatment

AnGes Group Receives FDA Approval of a Revised SPA for Phase III Clinical Trial for Collategene, a Drug for Ischemic Disease Treatment

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード